Systematic analysis of the relationship between ovarian cancer prognosis and alternative splicing

Di Zhang, Dan Zou, Yue Deng, Lihua YangJournal of Ovarian Research 2021 · DOI

TL;DR

This study systematically analyzes the relationship between alternative splicing (AS) events and splicing factors (SFs) with ovarian cancer (OC) prognosis. By building prognostic models based on these factors, the researchers identified key AS events and SFs that can serve as potential biomarkers for improving patient survival, highlighting the complex interplay between splicing and cancer progression.

What Problem Does This Paper Address?

Ovarian cancer (OC) is a deadly gynecological malignancy with a high mortality rate, underscoring the critical need for effective prognostic biomarkers. While alternative splicing (AS) – a process where a single gene can produce multiple protein variants – has been implicated in various diseases, including cancer, a comprehensive understanding of its role in OC prognosis and the influence of splicing factors (SFs) has been lacking. Previous studies have explored the association between AS and OC, but a systematic analysis integrating AS events, SFs, and prognostic modeling was needed to identify robust predictive markers.

Methods

The researchers employed a multi-faceted bioinformatics approach:

  • Data Acquisition: Clinical and transcriptomic data from OC patients were downloaded from The Cancer Genome Atlas (TCGA) database.
  • Alternative Splicing Event (ASE) Analysis: They analyzed seven types of AS events (Exon Skip (ES), Retained Intron (RI), Alternate Donor site (AD), Alternate acceptor site (AA), Alternate promoter (AP), Alternate terminator (AT), and Mutually exclusive exons (ME)) using Percent-splice-in (PSI) values.
  • Prognostic Modeling:
    • Univariate Cox Regression: Used to identify AS events significantly associated with overall survival (OS).
  • LASSO Regression: Applied to select the optimal number of AS events for constructing prognostic models.
  • Multivariate Cox Regression: Used to build eight prognostic models (one for each AS type and one for all types combined) and identify independent prognostic factors.
  • Survival Analysis: Kaplan-Meier survival curves were generated to compare survival differences between high- and low-risk groups defined by the prognostic models.
  • Receiver Operating Characteristic (ROC) Curves: Used to evaluate the accuracy and performance of the developed prognostic models.
  • Independent Prognostic Factor Analysis: Both single-factor and multi-factor analyses were conducted to determine if age and the risk score from the models were independent predictors of OS.
  • Splicing Factor (SF) Analysis: Univariate Cox regression was used to analyze the relationship between SF genes and AS events.
  • Network Construction: A correlation network was built using Cytoscape to visualize the relationships between SF genes and AS events.
  • Functional Enrichment Analysis: Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed on SF genes to understand their associated biological pathways.

Datasets

The study utilized data from the TCGA database, which provided clinical and transcriptomic data for 587 OC samples. After preprocessing and filtering, 384 samples with survival times greater than 90 days were included. Additionally, 404 human SF genes were obtained from previous literature.

Key Insights and Ideas

  • AS is Pervasive in OC: The study confirmed that a significant number of AS events are associated with OC prognosis, suggesting that altered splicing plays a crucial role in cancer development and progression.
  • SFs as Regulators: Splicing factors (SFs) are not just passive players but actively regulate AS events, and these SFs, in turn, can directly or indirectly influence OC prognosis.
  • Prognostic Models Show Promise: The developed prognostic models, built using AS events, demonstrated good accuracy in evaluating OC patient prognosis, indicating their potential as clinical tools.
  • Age and Risk Score as Key Predictors: Both patient age and the risk score derived from the prognostic models were identified as independent prognostic factors for OC, reinforcing their clinical relevance.
  • Complex SF-AS Relationships: The network analysis revealed that the relationship between SFs and AS events is not always one-to-one, but can be many-to-one or many-to-many, highlighting the intricate regulatory landscape.
  • Functional Pathways Identified: GO and KEGG enrichment analyses pointed to SFs being involved in critical biological processes such as RNA transport, degradation, and processing, which are fundamental to cellular function and cancer biology.

Key Results

  • Numerous OS-Related AS Events: Out of 31,286 overall survival (OS) related AS events, 1524 were found to be significantly correlated with OS.
  • High AUC Values: The prognostic models achieved good accuracy, with the Area Under the Curve (AUC) values ranging from 0.680 to 0.757, indicating their predictive capability. The AT and ME types showed the largest AUCs.
  • Significant Survival Differences: The survival curves demonstrated significant differences between high- and low-risk groups, with the AP type showing the most pronounced difference (P value of 1.61e-14).
  • Independent Prognostic Factors: Age (P=0.015, HR=1.016) and the risk score (P<0.001, HR=1.049) were identified as independent prognostic factors for OC.
  • SF-AS Correlations: 109 SF genes were found to be correlated with AS events, with both positive and negative regulatory relationships observed.

Limitations and Future Work

The authors acknowledge several limitations:

  • Lack of Control Cohort: The study did not include adjacent normal samples for comparison, which could provide a more comprehensive understanding of AS event changes.
  • Online Data Reliance: The data were sourced from TCGA and literature, and the findings may not be directly applicable to clinical patients without further validation.
  • Need for Clinical Cohort: The authors emphasize the urgent need to establish a clinical cohort to verify the results and the proposed mechanisms.
  • Mechanism Excavation: Further research is required to fully elucidate the mechanisms of the pathways identified through GO and KEGG enrichment analysis.

Future work should focus on exploring these pathways in more detail and validating the identified prognostic markers in clinical settings to ultimately improve OC treatment strategies.

Summary updated

Abstract

SFs and AS events can directly or indirectly affect the prognosis of OC patients. It is very important to find effective prognostic markers to improve the survival rate of OC.
BibTeX
@article{zhang2021systematic,
  author = {Di Zhang and Dan Zou and Yue Deng and Lihua Yang},
  title = {{Systematic analysis of the relationship between ovarian cancer prognosis and alternative splicing}},
  journal = {Journal of Ovarian Research},
  year = {2021},
  doi = {10.1186/s13048-021-00866-1},
}
Figure